Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer and HIV Vaccines Enter the Therapeutic Era

2.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

3.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

4.

Firefighters who eat better can combat cancer.

5.

Prostate cancer therapies: AI-based image analysis detects early organ damage


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot